
pmid: 19195540
Positron emission tomography (PET) and combined PET/CT provide powerful metabolic and anatomical information together in a single exam. This article reviews the fundamentals of PET physics, the state of the art and future directions in PET technology, and the current clinical applications of PET. The latter is quite diverse and includes oncology, cardiology, neurology, and infection and inflammation imaging, all with FDG as the tracer. Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism.
Fluorodeoxyglucose F18, Positron-Emission Tomography, Image Interpretation, Computer-Assisted, Image Processing, Computer-Assisted, Contrast Media, Humans, Equipment Design, Radiopharmaceuticals, Image Enhancement, Tomography, X-Ray Computed
Fluorodeoxyglucose F18, Positron-Emission Tomography, Image Interpretation, Computer-Assisted, Image Processing, Computer-Assisted, Contrast Media, Humans, Equipment Design, Radiopharmaceuticals, Image Enhancement, Tomography, X-Ray Computed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 70 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
